91奇迹

 找回密码
 中文注册
查看: 2878|回复: 3

ALK,ROS1的新药rxdx-101,3月31日开临床了

[复制链接]
发表于 2014-4-2 20:05:51 | 显示全部楼层 |阅读模式 来自: 中国上海
More data about upcoming Ignyta RDX-101 Phase I trial for ROS1 and ALK:

"RXDX-101: RXDX-101 is a new chemical entity that we in-licensed from Nerviano Medical Sciences (Nerviano) in October 2013. RXDX-101 is an orally available, selective tyrosine kinase inhibitor of the TrkA, TrkB, TrkC, ROS1 and ALK proteins. RXDX-101 is designed as a targeted therapeutic candidate to treat patients with cancers that harbor activating alterations to TrkA, TrkB, TrkC, ROS1 and ALK. Candidate alterations include gene rearrangements or mutations, splice variants, increased gene copy number and increased gene expression. RXDX-101 is currently in an ongoing Phase I/II study."
from

The phase 1/2a study is now listed on clinicaltrials.gov, but is not yet recruiting and lists no locations.
Inclusion criteria:
--Locally advanced or metastatic solid tumors that have a TrkA, TrkB, TrkC, ROS1, or ALK molecular alteration (non-small cell lung cancer, colorectal cancer, prostate cancer, papillary thyroid cancer, pancreatic cancer, and neuroblastoma)
--Prior cancer therapy is allowed, including crizotinib and investigational drugs (7-day washout if prior therapy had no toxicity)
--Patients with controlled asymptomatic central nervous system involvement are allowed if not taking anticonvulsants

Craig has heard Massachusetts General in Boston will have this trial, and I have heard University of Colorado will probably have it also.
看了要求,排除了脑转,估计不入脑,是不是3代药未知啊
有爱,就有奇迹!
发表于 2014-7-20 13:52:56 | 显示全部楼层 来自: 中国上海
不知道中国什么时候有实验组?
有爱,就有奇迹!
发表于 2015-5-11 06:43:21 | 显示全部楼层 来自: 中国广西桂林
有新药就值得庆幸,多一条路和办法!
有爱,就有奇迹!
发表于 2015-10-22 09:41:48 | 显示全部楼层 来自: 中国广东佛山
听说最近中国在研究,望能快些,造福患者。
有爱,就有奇迹!
您需要登录后才可以回帖 登录 | 中文注册

本版积分规则

QQ|关于我们|隐私服务条款|小黑屋|手机版|91奇迹 ( 京ICP备2020048145号-6 )

GMT+8, 2024-11-23 18:24 , Processed in 0.047304 second(s), 18 queries .

Powered by Discuz! X3.4

Copyright © 2001-2023, Tencent Cloud.

快速回复 返回顶部 返回列表